Analysts' Top Healthcare Picks: Laboratory (LH), Humana (HUM)
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Evolus (EOLS) and Humana (HUM)
Humana Analyst Ratings
TD Cowen Maintains Humana(HUM.US) With Buy Rating, Cuts Target Price to $402
TD Cowen Cuts Humana's Price Target to $402 From $407
Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $364
Jefferies Adjusts Price Target on Humana to $419 From $365
Jefferies Maintains Humana(HUM.US) With Buy Rating, Raises Target Price to $419
Humana's Balanced Market Outlook and Cost Control Recovery Justify Buy Rating
Humana Analyst Ratings
Oppenheimer Maintains Humana(HUM.US) With Buy Rating, Raises Target Price to $400
Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Jazz Pharmaceuticals (JAZZ) and Humana (HUM)
Truist Financial Sticks to Their Hold Rating for Humana (HUM)
Truist Financial Maintains Humana(HUM.US) With Hold Rating
Humana Inc. (HUM) Outshines Expectations With Strong Q2 Performance and Positive Outlook: A 'Buy' Rating Justified
Barclays Maintains Humana(HUM.US) With Hold Rating, Cuts Target Price to $364
Humana (HUM) Gets a Hold From Barclays
TD Cowen Maintains Humana(HUM.US) With Buy Rating, Maintains Target Price $407
TD Cowen Initiates Humana(HUM.US) With Buy Rating, Announces Target Price $407
Cantor Fitzgerald Keeps Their Hold Rating on Humana (HUM)